This one is a hard pill to swallow. Eli Lilly and Co. (LLY) and AstraZeneca PLC …
At the closing bell on the stock market today, Alder popped 6.7%, to 17.65. …
Insiders are masters of snatching up shares of their companies at a discount, …
JAK inhibitors were in the news this week with Eli Lilly (NYSE: LLY) finally gaining FDA approval for its rheumatoid arthritis ("RA") candidate Olumiant (baricitinib) in the United States while AbbVie (NYSE: ABBV) presented positive top-line …
The rating was maintained by Jefferies with “Buy” on Friday, March 23. The stock of Eli Lilly and Company (NYSE:LLY) has “Hold” rating given on Thursday, February 1 by Leerink Swann. Barclays Capital maintained the shares of LLY in …
Merck’s supplemental Biologics License Application (“sBLA”) seeking continued …
It’s a busy week for pharmaceutical companies, with Eli Lilly And Co (NYSE:LLY), Biogen Inc (NASDAQ:BIIB), and Amgen, Inc. (NASDAQ:AMGN) having released their earnings report today. For Eli Lilly stock, investors sought a …
AstraZeneca (AZN) and Eli Lilly (LLY) became the latest Tuesday in a series of pharmaceutical ... Researchers believe the toxic substance is at the center of …